ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia in Adolescents and Young Adults
ASH Seeks Public Comment on Draft Recommendations for New Guidelines on Frontline Management and Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYAs).
ASH is now accepting public comments on draft recommendations on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYAs). Comments will be accepted until October 29, 2024. We encourage all interested healthcare professionals, stakeholder organizations, and individuals to share their feedback on these draft recommendations. All comments will be reviewed by the guideline panel before the guidelines are finalized.
Frontline Management of ALL in AYA Draft Recommendations
Relapsed/Refractory Management of ALL in AYA Draft Recommendations
Please submit all comments to [email protected].
ASH is developing new clinical practice guidelines for the treatment of adolescents and young adults with acute lymphoblastic leukemia (ALL). This project was proposed and approved by ASH members in 2019, leadership was selected in 2020, and nominations for the guideline panels were solicited in 2021.
Guidelines are now available for public comment.